Clinical Trial Update: Testing of Drugs Erlotinib and Docetaxel in Lung Cancer Patients Classified Regarding Their Outlook Using VeriStrat®. [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluated erlotinib and docetaxel in non-small cell lung cancer patients stratified by VeriStrat status; results completed and posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• ERLOTINIB (Erlotinib)

Snippet

Sponsor: ETOP IBCSG Partners Foundation | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 3 | Status: COMPLETED | Results posted: 2019-08-08